AYR-A:CA:CNSX-Ayr Wellness Inc (CAD)

COMMON STOCK | Drug Manufacturers-Specialty & Generic | CNSX

Last Closing Price

CAD 20.81

Change

-0.19 (-0.90)%

Market Cap

CAD 1.39B

Volume

0.14M

Avg Analyst Target

N/A

Avg User Target

CAD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Ayr Wellness Inc (AYR-A) Stock Analysis:
Based on the Ayr Wellness Inc stock forecasts from 0 analysts, the average analyst target price for Ayr Wellness Inc is not available over the next 12 months. Ayr Wellness Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Ayr Wellness Inc is Neutral, which is based on 2 positive signals and 2 negative signals. At the last closing, Ayr Wellness Inc’s stock price was CAD 20.81. Ayr Wellness Inc’s stock price has changed by -0.59% over the past week, +4.20% over the past month and +0.00% over the last year.

About

Ayr Wellness Inc., a vertically-integrated cannabis multi-state operator, cultivates, extracts, manufactures, distributes, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizer ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-19 )

Largest Industry Peers for Drug Manufacturers-Specialty & Generic

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CURA:CA Curaleaf Holdings Inc

-0.09 (-0.87%)

CAD7.26B N/A 32.60
TRUL:CA Trulieve Cannabis Corp

-1.04 (-3.37%)

CAD5.98B 35.92 20.67
GTII:CA Green Thumb Industries Inc

+0.63 (+2.48%)

CAD5.75B 60.12 20.34
VRNO:CA Verano Holdings Corp

-0.70 (-4.53%)

CAD3.13B 21.02 22.36
CL:CA Cresco Labs Inc

-0.23 (-2.68%)

CAD2.28B N/A 20.98
HARV:CA Harvest Health & Recreation In..

N/A

CAD1.65B N/A 122.88
CCHW:CA Columbia Care Inc

-0.01 (-0.25%)

CAD1.47B N/A 127.53
TER:CA TerrAscend Corp

-0.26 (-3.71%)

CAD1.25B N/A 81.47
JUSH:CA Jushi Holdings Inc

+0.12 (+2.40%)

CAD1.00B N/A N/A
PLTH:CA Planet 13 Holdings Inc

-0.06 (-1.53%)

CAD0.76B N/A 136.55

ETFs Containing AYR-A:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-Specialty & Generic)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.73% 71% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.73% 71% C- 71% C-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 1.39B 95% A 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-Specialty & Generic)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 0.99 70% C- 78% C+
Price / Cash Flow Ratio 38.00 6% F 4% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -33.80% 69% D+ 73% C
Return on Invested Capital -1.79% 79% C+ 77% C+
Return on Assets 1.72% 88% B+ 94% A
Debt to Equity Ratio 104.23% 11% F 9% F
Technical Ratios  
Short Ratio 0.85 28% F 24% F
Short Percent 0.83% 5% F 4% F
Beta 1.41 39% F 43% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.